| Dr James R Rooks, MD | |
|
1190 N State St, Suite 502, Jackson, MS 39202-2413 | |
| (601) 944-1781 | |
| (601) 353-0439 |
| Full Name | Dr James R Rooks |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 38 Years |
| Location | 1190 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962451898 | NPI | - | NPPES |
| 00115442 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 11414 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sta Home Health And Hospice | Clinton, MS | Home health agency |
| Mississippi Baptist Medical Center | Jackson, MS | Hospital |
| Merit Health Central | Jackson, MS | Hospital |
| S E Lackey Memorial Hospital | Forest, MS | Hospital |
| Merit Health River Oaks | Flowood, MS | Hospital |
| King's Daughters Medical Center-brookhaven | Brookhaven, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Surgical Associates | 1355359506 | 12 |
News Archive
Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the "dark matter" of the genome and has begun to explore a possible new approach to treating cancer.
The New South Wales Nurses Association warned that it would keep closing-down beds at Royal Prince Alfred hospital in Sydney's inner west and the Wollongong Hospital until a consensus is reached regarding staffing levels. This Tuesday 40 beds were closed at Wollongong protesting to see a one-nurse-to-four-patient ratio introduced. Beds in the pediatric, intensive care and maternity and emergency wards are spared. Some surgical, rehabilitative and aged care beds are closed.
Virginia Commonwealth University researchers have found that intrauterine devices are safe and effective in a population of women previously not considered as good candidates for this method of birth control.
Almirall strengthens its position in the respiratory field with a positive development progress of another New Chemical Entity (NCE). LAS190792 is a new dual long-acting Muscarinic Antagonist β2 Agonist (MABA), which combines two bronchodilator mechanisms in a single molecule for the treatment of COPD.
Studying a protein already known to play an important role in type 2 diabetes and cancer, genomics researchers have discovered that it may have an even broader role in disease, particularly in other metabolic disorders and heart disease. In finding unsuspected links to other disease-related genes, the scientists may have identified future targets for drug treatments.
› Verified 8 days ago
| Entity Name | Independent Healthcare Management Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306909734 PECOS PAC ID: 0840197232 Enrollment ID: O20031215000487 |
News Archive
Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the "dark matter" of the genome and has begun to explore a possible new approach to treating cancer.
The New South Wales Nurses Association warned that it would keep closing-down beds at Royal Prince Alfred hospital in Sydney's inner west and the Wollongong Hospital until a consensus is reached regarding staffing levels. This Tuesday 40 beds were closed at Wollongong protesting to see a one-nurse-to-four-patient ratio introduced. Beds in the pediatric, intensive care and maternity and emergency wards are spared. Some surgical, rehabilitative and aged care beds are closed.
Virginia Commonwealth University researchers have found that intrauterine devices are safe and effective in a population of women previously not considered as good candidates for this method of birth control.
Almirall strengthens its position in the respiratory field with a positive development progress of another New Chemical Entity (NCE). LAS190792 is a new dual long-acting Muscarinic Antagonist β2 Agonist (MABA), which combines two bronchodilator mechanisms in a single molecule for the treatment of COPD.
Studying a protein already known to play an important role in type 2 diabetes and cancer, genomics researchers have discovered that it may have an even broader role in disease, particularly in other metabolic disorders and heart disease. In finding unsuspected links to other disease-related genes, the scientists may have identified future targets for drug treatments.
› Verified 8 days ago
| Entity Name | Central Surgical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639295009 PECOS PAC ID: 1355359506 Enrollment ID: O20060329000399 |
News Archive
Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the "dark matter" of the genome and has begun to explore a possible new approach to treating cancer.
The New South Wales Nurses Association warned that it would keep closing-down beds at Royal Prince Alfred hospital in Sydney's inner west and the Wollongong Hospital until a consensus is reached regarding staffing levels. This Tuesday 40 beds were closed at Wollongong protesting to see a one-nurse-to-four-patient ratio introduced. Beds in the pediatric, intensive care and maternity and emergency wards are spared. Some surgical, rehabilitative and aged care beds are closed.
Virginia Commonwealth University researchers have found that intrauterine devices are safe and effective in a population of women previously not considered as good candidates for this method of birth control.
Almirall strengthens its position in the respiratory field with a positive development progress of another New Chemical Entity (NCE). LAS190792 is a new dual long-acting Muscarinic Antagonist β2 Agonist (MABA), which combines two bronchodilator mechanisms in a single molecule for the treatment of COPD.
Studying a protein already known to play an important role in type 2 diabetes and cancer, genomics researchers have discovered that it may have an even broader role in disease, particularly in other metabolic disorders and heart disease. In finding unsuspected links to other disease-related genes, the scientists may have identified future targets for drug treatments.
› Verified 8 days ago
| Entity Name | Independent Healthcare Management Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1306909734 PECOS PAC ID: 0840197232 Enrollment ID: O20120111000488 |
News Archive
Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the "dark matter" of the genome and has begun to explore a possible new approach to treating cancer.
The New South Wales Nurses Association warned that it would keep closing-down beds at Royal Prince Alfred hospital in Sydney's inner west and the Wollongong Hospital until a consensus is reached regarding staffing levels. This Tuesday 40 beds were closed at Wollongong protesting to see a one-nurse-to-four-patient ratio introduced. Beds in the pediatric, intensive care and maternity and emergency wards are spared. Some surgical, rehabilitative and aged care beds are closed.
Virginia Commonwealth University researchers have found that intrauterine devices are safe and effective in a population of women previously not considered as good candidates for this method of birth control.
Almirall strengthens its position in the respiratory field with a positive development progress of another New Chemical Entity (NCE). LAS190792 is a new dual long-acting Muscarinic Antagonist β2 Agonist (MABA), which combines two bronchodilator mechanisms in a single molecule for the treatment of COPD.
Studying a protein already known to play an important role in type 2 diabetes and cancer, genomics researchers have discovered that it may have an even broader role in disease, particularly in other metabolic disorders and heart disease. In finding unsuspected links to other disease-related genes, the scientists may have identified future targets for drug treatments.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James R Rooks, MD 1190 N State St, Suite 502, Jackson, MS 39202-2413 Ph: (601) 944-1781 | Dr James R Rooks, MD 1190 N State St, Suite 502, Jackson, MS 39202-2413 Ph: (601) 944-1781 |
News Archive
Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the "dark matter" of the genome and has begun to explore a possible new approach to treating cancer.
The New South Wales Nurses Association warned that it would keep closing-down beds at Royal Prince Alfred hospital in Sydney's inner west and the Wollongong Hospital until a consensus is reached regarding staffing levels. This Tuesday 40 beds were closed at Wollongong protesting to see a one-nurse-to-four-patient ratio introduced. Beds in the pediatric, intensive care and maternity and emergency wards are spared. Some surgical, rehabilitative and aged care beds are closed.
Virginia Commonwealth University researchers have found that intrauterine devices are safe and effective in a population of women previously not considered as good candidates for this method of birth control.
Almirall strengthens its position in the respiratory field with a positive development progress of another New Chemical Entity (NCE). LAS190792 is a new dual long-acting Muscarinic Antagonist β2 Agonist (MABA), which combines two bronchodilator mechanisms in a single molecule for the treatment of COPD.
Studying a protein already known to play an important role in type 2 diabetes and cancer, genomics researchers have discovered that it may have an even broader role in disease, particularly in other metabolic disorders and heart disease. In finding unsuspected links to other disease-related genes, the scientists may have identified future targets for drug treatments.
› Verified 8 days ago
Dr. Wayne Shannon Orr Iii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5452 Fax: 601-815-3322 | |
Jacob M Folse, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5153 Fax: 601-984-6962 | |
Robert Eugene Schmieg Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 Fax: 601-926-4978 | |
Dr. Hal Gregory Fiser, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1190 N State St, Suite 502, Jackson, MS 39202 Phone: 601-944-1781 Fax: 601-353-0439 | |
Pierre Edouard De Delva, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, University Of Mississippi Medical Center, Jackson, MS 39216 Phone: 601-984-5170 | |
Dr. John Magruder Sullivan Iii, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 | |
Colton Lott, Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-1292 Fax: 601-984-5110 |